Location
Philadelphia, PA
Start Date
30-4-2025 1:00 PM
End Date
30-4-2025 4:00 PM
Description
The use of nanoparticles has emerged as a promising approach to overcoming clinical challenges faced by physicians and scientists striving to enhance drug bioavailability, improve diagnostics, and promote tissue regeneration. Among these, phase-transferred plasmonic nanoparticles—known for their highly tunable optical properties—have shown significant potential in various biomedical applications. These include surface functionalization for enhanced biocompatibility, antimicrobial treatments, advanced sensing and diagnostic tools, drug delivery systems, photothermal therapy, and imaging technologies.
This systematic review explores recent applications of phase-transferred plasmonic nanoparticles in improving therapeutic outcomes in human subjects. A comprehensive analysis of peer-reviewed studies from major literature databases was conducted, focusing on plasmonic metal nanoparticles (primarily Ag, Au, Pt, Pd, Cu, and their alloys) dispersed in organic solvents. The findings indicate that these nanoparticles contribute to positive clinical outcomes, such as improved anti-inflammatory responses, reduced oxidative stress, and enhanced patient-reported outcomes in chronic diseases. However, the review also highlights significant variability in nanoparticle formulations, underscoring the need for standardized methodologies to optimize their therapeutic potential.
Embargo Period
5-29-2025
Included in
Phase transfer of Plasmonic Nanoparticles: A gateway to biomedical Innovations
Philadelphia, PA
The use of nanoparticles has emerged as a promising approach to overcoming clinical challenges faced by physicians and scientists striving to enhance drug bioavailability, improve diagnostics, and promote tissue regeneration. Among these, phase-transferred plasmonic nanoparticles—known for their highly tunable optical properties—have shown significant potential in various biomedical applications. These include surface functionalization for enhanced biocompatibility, antimicrobial treatments, advanced sensing and diagnostic tools, drug delivery systems, photothermal therapy, and imaging technologies.
This systematic review explores recent applications of phase-transferred plasmonic nanoparticles in improving therapeutic outcomes in human subjects. A comprehensive analysis of peer-reviewed studies from major literature databases was conducted, focusing on plasmonic metal nanoparticles (primarily Ag, Au, Pt, Pd, Cu, and their alloys) dispersed in organic solvents. The findings indicate that these nanoparticles contribute to positive clinical outcomes, such as improved anti-inflammatory responses, reduced oxidative stress, and enhanced patient-reported outcomes in chronic diseases. However, the review also highlights significant variability in nanoparticle formulations, underscoring the need for standardized methodologies to optimize their therapeutic potential.